EMA-话题@MedSci

#EMA#

580篇内容 | 2464人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317453, encodeId=e63c131e45308, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响, objectType=article, longId=158923, objectId=ebd9158923fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebd9158923fd, replyNumber=0, likeNumber=67, createdTime=2019-01-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebd9158923fd, moduleTitle=Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebd9158923fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317452, encodeId=3435131e452fc, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=INT J LAB HEMATOL：t(821) (q22q22)急性髓系白血病免疫表型特征及流式细胞术评分系统, objectType=article, longId=158609, objectId=65b0158609ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65b0158609ca, replyNumber=0, likeNumber=83, createdTime=2019-01-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65b0158609ca, moduleTitle=INT J LAB HEMATOL：t(821) (q22q22)急性髓系白血病免疫表型特征及流式细胞术评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65b0158609ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317451, encodeId=cdfa131e451b2, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=INT J LAB HEMATOL：全血细胞计数的质量控制如何实现？, objectType=article, longId=158608, objectId=52b2158608f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52b2158608f0, replyNumber=0, likeNumber=78, createdTime=2019-01-23, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52b2158608f0, moduleTitle=INT J LAB HEMATOL：全血细胞计数的质量控制如何实现？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52b2158608f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317450, encodeId=c2d0131e45000, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：淋巴瘤：蒽环类药物的心脏毒性风险令人大惊失色！, objectType=article, longId=158416, objectId=45b5158416c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45b5158416c8, replyNumber=0, likeNumber=64, createdTime=2019-01-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45b5158416c8, moduleTitle=Br J Haematol：淋巴瘤：蒽环类药物的心脏毒性风险令人大惊失色！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45b5158416c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317449, encodeId=d899131e4496c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：确认过眼神！体力活动可改善淋巴瘤患者生存, objectType=article, longId=158334, objectId=ece515833461, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ece515833461, replyNumber=0, likeNumber=97, createdTime=2019-01-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ece515833461, moduleTitle=Am J Hematol：确认过眼神！体力活动可改善淋巴瘤患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ece515833461)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317448, encodeId=253d131e448e7, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, objectType=article, longId=158333, objectId=632d1583337f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=632d1583337f, replyNumber=0, likeNumber=71, createdTime=2019-01-19, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=632d1583337f, moduleTitle=Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=632d1583337f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317447, encodeId=c0bd131e447cf, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：儿童溃疡性结肠炎发作相关贫血口服补铁就可搞定？, objectType=article, longId=158206, objectId=def71582066b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=def71582066b, replyNumber=0, likeNumber=74, createdTime=2019-01-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=def71582066b, moduleTitle=Am J Hematol：儿童溃疡性结肠炎发作相关贫血口服补铁就可搞定？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=def71582066b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317446, encodeId=1470131e44642, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Clin Exp Metastasis：HIF-1α增加Sema4D的表达和分泌，抑制肺癌骨转移中的成骨, objectType=article, longId=157775, objectId=2bf615e7752c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bf615e7752c, replyNumber=0, likeNumber=50, createdTime=2019-01-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bf615e7752c, moduleTitle=Clin Exp Metastasis：HIF-1α增加Sema4D的表达和分泌，抑制肺癌骨转移中的成骨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bf615e7752c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317445, encodeId=0d1a131e445b1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematology：重磅！中国PD-1抑制剂信迪利单抗治疗cHL关键研究荣登《柳叶刀血液病学》封面, objectType=article, longId=157428, objectId=9bed15e428fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bed15e428fb, replyNumber=0, likeNumber=66, createdTime=2019-01-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bed15e428fb, moduleTitle=Lancet Haematology：重磅！中国PD-1抑制剂信迪利单抗治疗cHL关键研究荣登《柳叶刀血液病学》封面, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bed15e428fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317444, encodeId=818e131e44473, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA已经开始审查含有磷霉素的药物, objectType=article, longId=155934, objectId=64131559348e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64131559348e, replyNumber=0, likeNumber=68, createdTime=2018-12-18, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64131559348e, moduleTitle=EMA已经开始审查含有磷霉素的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64131559348e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317443, encodeId=e7a2131e443b0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, objectType=article, longId=155661, objectId=4497155661dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4497155661dc, replyNumber=0, likeNumber=48, createdTime=2018-12-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4497155661dc, moduleTitle=J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4497155661dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317442, encodeId=7856131e4420f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：延缓晚期骨髓纤维变性患者骨髓纤维化进展鲁索利替尼大放异彩, objectType=article, longId=155659, objectId=450b15565932, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450b15565932, replyNumber=0, likeNumber=49, createdTime=2018-12-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450b15565932, moduleTitle=J Hematol Oncol：延缓晚期骨髓纤维变性患者骨髓纤维化进展鲁索利替尼大放异彩, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450b15565932)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317441, encodeId=b0ba131e441cb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=J Hematol Oncol：未经治的转移性肾细胞癌患者使用帕唑帕尼和舒尼替尼安全吗？, objectType=article, longId=155658, objectId=3144155658f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3144155658f9, replyNumber=0, likeNumber=36, createdTime=2018-12-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3144155658f9, moduleTitle=J Hematol Oncol：未经治的转移性肾细胞癌患者使用帕唑帕尼和舒尼替尼安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3144155658f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317440, encodeId=589a131e4401a, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？, objectType=article, longId=155657, objectId=637315565e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=637315565e43, replyNumber=0, likeNumber=66, createdTime=2018-12-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=637315565e43, moduleTitle=Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=637315565e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317439, encodeId=5581131e43958, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Alembic制药宣布美国FDA已正式批准其不同剂量的Temazepam胶囊, objectType=article, longId=154606, objectId=d482154606ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d482154606ea, replyNumber=0, likeNumber=59, createdTime=2018-11-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d482154606ea, moduleTitle=Alembic制药宣布美国FDA已正式批准其不同剂量的Temazepam胶囊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d482154606ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317438, encodeId=75c4131e43802, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者, objectType=article, longId=154098, objectId=33f915409826, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33f915409826, replyNumber=0, likeNumber=52, createdTime=2018-11-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33f915409826, moduleTitle=CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33f915409826)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317437, encodeId=1ac0131e43728, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA：潜在的永久性副作用导致喹诺酮和氟喹诺酮抗生素的停用或限制, objectType=article, longId=153909, objectId=50c715390974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50c715390974, replyNumber=0, likeNumber=54, createdTime=2018-11-21, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50c715390974, moduleTitle=EMA：潜在的永久性副作用导致喹诺酮和氟喹诺酮抗生素的停用或限制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50c715390974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317436, encodeId=5162131e43692, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA委员会支持批准赛诺菲的fexinidazole治疗昏睡病, objectType=article, longId=153844, objectId=f484153844be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f484153844be, replyNumber=0, likeNumber=56, createdTime=2018-11-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f484153844be, moduleTitle=EMA委员会支持批准赛诺菲的fexinidazole治疗昏睡病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f484153844be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317435, encodeId=f05c131e43567, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人, objectType=article, longId=153070, objectId=9c1a1530e044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c1a1530e044, replyNumber=0, likeNumber=75, createdTime=2018-11-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c1a1530e044, moduleTitle=Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c1a1530e044)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317434, encodeId=78c9131e434fa, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：TD MDS和非TD MDS患者谁能从来那度胺获益？, objectType=article, longId=153067, objectId=314915306eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=314915306eaf, replyNumber=0, likeNumber=62, createdTime=2018-11-10, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=314915306eaf, moduleTitle=Am J Hematol：TD MDS和非TD MDS患者谁能从来那度胺获益？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=314915306eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响

2019-01-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

INT J LAB HEMATOL：t(821) (q22q22)急性髓系白血病免疫表型特征及流式细胞术评分系统

2019-01-23

医者仁心 (审核中...)

前往app查看评论内容

#EMA#

INT J LAB HEMATOL：全血细胞计数的质量控制如何实现？

2019-01-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：淋巴瘤：蒽环类药物的心脏毒性风险令人大惊失色！

2019-01-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：确认过眼神！体力活动可改善淋巴瘤患者生存

2019-01-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：MYC基因重排侵袭性B细胞淋巴瘤可考虑剂量调整的EPOCH-R方案

2019-01-19

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：儿童溃疡性结肠炎发作相关贫血口服补铁就可搞定？

2019-01-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Clin Exp Metastasis：HIF-1α增加Sema4D的表达和分泌，抑制肺癌骨转移中的成骨

2019-01-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematology：重磅！中国PD-1抑制剂信迪利单抗治疗cHL关键研究荣登《柳叶刀血液病学》封面

2019-01-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA已经开始审查含有磷霉素的药物

2018-12-18

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：套细胞淋巴瘤自体造血干细胞移植后硼替佐米+利妥昔单抗疗效喜人

2018-12-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：延缓晚期骨髓纤维变性患者骨髓纤维化进展鲁索利替尼大放异彩

2018-12-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

J Hematol Oncol：未经治的转移性肾细胞癌患者使用帕唑帕尼和舒尼替尼安全吗？

2018-12-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：R-CHOP作为新确诊晚期滤泡性淋巴瘤患者一线治疗怎么样？

2018-12-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Alembic制药宣布美国FDA已正式批准其不同剂量的Temazepam胶囊

2018-11-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

CLIN CANCER RES：Abemaciclib联合其他药物治疗非小细胞肺癌患者

2018-11-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA：潜在的永久性副作用导致喹诺酮和氟喹诺酮抗生素的停用或限制

2018-11-21

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA委员会支持批准赛诺菲的fexinidazole治疗昏睡病

2018-11-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：套细胞淋巴瘤：利妥昔单抗维持治疗效果喜人

2018-11-10

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：TD MDS和非TD MDS患者谁能从来那度胺获益？

2018-11-10

科室
- - 订阅+
  - 更多科室
工具
服务